AzTrials
AzTrials

AnesthesiaNCT01824914

Airway Evaluation by McGrath Videolaryngoscope

A study testing McGrath Videolaryngoscope in people with Anesthesia, run by Huazhong University of Science and Technology at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Difficult tracheal intubation is a cause of severe patient damage and death. There is not a good method to predict it. The McGrath Series 5 video laryngoscope can improve visualization of the glottic structures one to two grades. Read more about this study

Who is it for?
Ages 15 to 65 years
Conditions the study is for
Anesthesia
What is being tested?
McGrath Videolaryngoscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
97 participants
Where
1 siteChina
Study dates
Apr 2013to Oct 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • patients scheduled for general surgery under general anesthesia
  • ASA classification 1-3

Who cannot join

  • emergent operation, aspiration risk
  • a history of difficult airway
  • expected difficult airway
  • incooperative patients with mental diseases, hearing disorders

Trial locations and contacts

1 site in 1 country.

China1 site
  • Tongji Hospital, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030

Other trials in China

About this study

Official title: Comparison of Cormack-Lehane Score in Sedation and Anesthesia Condition by McGrath Videolaryngoscope

Difficult tracheal intubation is a cause of severe patient damage and death. There is not a good method to predict it. The McGrath Series 5 video laryngoscope can improve visualization of the glottic structures one to two grades. Moreover unlike a classical laryngoscope with a Macintosh blade, the McGrath provides a view of the glottis without requiring alignment of the oral, pharyngeal and laryngeal axes. In this study, the investigators will use it to compare the Cormack-Lehane score in sedation and anesthesia condition. It helps to know the role of videolaryngoscope in predicting difficult intubation.

Read the detailed description
  • The enrolled patients were given a bolus of sufentanil 0.3-0.5μg/kg to achieve Ramsay sedation score 2-3. The Cormack-Lehane score in sedation was evaluated by McGrath videolaryngoscope.
  • Then the patients were induced with propofol. A bolus of rocuronium was given to facilitate intubation. The Cormack-Lehane score in anesthesia was recorded when intubated by McGrath videolaryngoscope.
  • BMI, mouth opening, thyromental distance, intubation duration and ramsay sedation score were also recorded.
  • To compare the Cormack-Lehane score in sedate and anesthesia condition
Conditions
Anesthesia
Being tested
McGrath Videolaryngoscope
Keywords
videolaryngoscope, tracheal intubation, Cormack-Lehane grade, airway evaluation, sedation, anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • McGrath VideolaryngoscopeDevice

    A kind of portable videolaryngoscopes, produced by Aircraft Medical. It has been used for difficult airway.

Study groups in NCT01824914
Study groupRoleWhat they receive
McGrath VideolaryngoscopeExperimentalto compare the Cormack-Lehane grade in sedation and anesthesia by McGrath videolaryngoscope
Receives: Device: McGrath Videolaryngoscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cormack-Lehane score in sedation condition

    Based on the Modified Cormack-Lehane classification. 5 degrades. 1-5

    Measured: 5 minutes after administration of sufentanil

  2. Cormack-lehane score in anesthesia condition

    Based on the Modified Cormack-Lehane classification. 5 degrades. 1-5

    Measured: 1 minute after administration of rocuronium

Secondary outcomes (2)
  1. Duration of intubation

    The duration of intubation is defined as the time from inserting videolaryngoscope, intubating a tube, to withdrawing videolaryngoscope using a stopwatch.

    Measured: At intubation

  2. Sedation score

    by Ramsay sedation score 1-6. The higher score, the deeper sedation

    Measured: 5 minutes after administraion of sufentanil

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2013 (estimated)
  2. Study startApr 2013
  3. Primary completionOct 2013
  4. Study completionOct 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
97 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01824914
Sponsor's protocol ID
TJMZK20121231
Status last verified
Nov 2014
First submitted
25 Mar 2013
Last updated
7 Nov 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing McGrath Videolaryngoscope in people with Anesthesia, run by Huazhong University of Science and Technology at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cormack-Lehane score in sedation condition (time frame: 5 minutes after administration of sufentanil). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in